2001
DOI: 10.1016/s0021-9150(01)00423-3
|View full text |Cite
|
Sign up to set email alerts
|

Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 −2518 G/G genotype in CAD patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

10
192
2
3

Year Published

2002
2002
2021
2021

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 284 publications
(207 citation statements)
references
References 30 publications
10
192
2
3
Order By: Relevance
“…Moreover, MCP-1 expression in isolated, cytokine-stimulated human peripheral blood mononuclear cells [22,25] and hepatic cells [26], and plasma MCP-1 levels in patients with lupus nephritis support the assumption that the gene polymorphism regulates MCP-1 expression at the transcriptional level [25]. Case-control gene association studies have reported statistical associations between the polymorphism and lupus nephritis [25], coronary artery disease (CAD) [27] and asthma [28]. The aim of the present study was to test the hypothesis that the MCP-1 A-2518G polymorphism influences plasma MCP-1 levels and the risk of developing insulin resistance and Type 2 diabetes.…”
Section: Introductionmentioning
confidence: 80%
“…Moreover, MCP-1 expression in isolated, cytokine-stimulated human peripheral blood mononuclear cells [22,25] and hepatic cells [26], and plasma MCP-1 levels in patients with lupus nephritis support the assumption that the gene polymorphism regulates MCP-1 expression at the transcriptional level [25]. Case-control gene association studies have reported statistical associations between the polymorphism and lupus nephritis [25], coronary artery disease (CAD) [27] and asthma [28]. The aim of the present study was to test the hypothesis that the MCP-1 A-2518G polymorphism influences plasma MCP-1 levels and the risk of developing insulin resistance and Type 2 diabetes.…”
Section: Introductionmentioning
confidence: 80%
“…The rare Val64Ile polymorphism in the CCR2 gene was associated with reduced coronary calcification, as well as MCP-1 G2518 homozygosity [36,37]. On the contrary Brenner et al demonstrated a A2518 association with increased IMT [38].…”
Section: Discussionmentioning
confidence: 99%
“…The SDF-1 3'A variant (801G to A in the 3'-untranslated region) was detected by electrophoresis on 2.5% agarose gel after PCR amplification and MspI (New England Biolabs, SaintQuentin-en-Yvelines, France) digestion as previously described [16] . Genotype analysis for MCP-1 (-2518) was performed on genomic DNA with PCR with sequencespecific primers followed by restriction fragment length polymorphism analysis as described [22,23] . Briefly, after PCR amplification, PCR products were digested with PvuⅡ (recognizes the MCP-1 -2518 A/G transition) (New England Biolabs).…”
Section: Follow-upmentioning
confidence: 99%